Citation: S. Bramer et al., RISK INDICATORS FOR NEONATAL EARLY-ONSET GBS-RELATED DISEASE - A CASE-CONTROL STUDY, Journal of perinatal medicine, 25(6), 1997, pp. 469-475
Citation: Ah. Adriaanse et al., IN-VITRO ACTIVITY OF CHLORHEXIDINE, HEXETIDINE AND BACITRACIN AGAINSTPERINATAL PATHOGENS, Journal of antimicrobial chemotherapy, 37(1), 1996, pp. 192-194
Citation: Ah. Adriaanse et al., NEONATAL EARLY-ONSET GROUP-B STREPTOCOCCAL INFECTION - A 9-YEAR RETROSPECTIVE STUDY IN A TERTIARY CARE HOSPITAL, Journal of perinatal medicine, 24(5), 1996, pp. 531-538
Citation: Ah. Adriaanse, PREVENTION OF NEONATAL SEPTICEMIA DUE TO GROUP-B STREPTOCOCCI, Bailliere's clinical obstetrics and gynaecology, 9(3), 1995, pp. 545-552
Citation: Ah. Adriaanse et al., RANDOMIZED STUDY OF VAGINAL CHLORHEXIDINE DISINFECTION DURING LABOR TO PREVENT VERTICAL TRANSMISSION OF GROUP-B STREPTOCOCCI, European journal of obstetrics, gynecology, and reproductive biology, 61(2), 1995, pp. 135-141
Citation: Ah. Adriaanse et al., SENSITIVITY OF INTRAPARTUM GROUP-B STREPTOCOCCAL SCREENING AND IN-VITRO COMPARISON OF 4 RAPID ANTIGEN TESTS, European journal of obstetrics, gynecology, and reproductive biology, 56(1), 1994, pp. 21-26